Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Vascular Therapies

Vascular Therapies
2001 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Series E2 LATEST DEAL TYPE
$12.4M LATEST DEAL AMOUNT
4 INVESTORS
Description

Developer of vascular therapies intended to harness local drug delivery to address unmet clinical needs. The company's therapies are used to offer biodegradable collagen implant to treat the problem of vascular anastomosis failure, enabling physicians to improve the outcomes of an Arterio-Venous Fistula (AVF) and improve their lives.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Delivery
Drug Discovery
Primary Office
  • 105 Union Avenue
  • Cresskill, NJ 07626
  • United States

+1 (201) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Vascular Therapies’s full profile, request a free trial.

Vascular Therapies Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC (Series E2) 10-Oct-2018 $12.4M 000.00 00000 Completed Generating Revenue
6. Later Stage VC (Series E) 14-Dec-2016 0000 000.00 00000 Completed Generating Revenue
5. Early Stage VC 12-Jul-2013 000.00 000.00 000.00 Completed Generating Revenue
4. Angel (individual) 22-Apr-2011 00.000 0000 Completed Generating Revenue
3. Grant 01-Jan-2009 00000 00.000 Completed Startup
2. Angel (individual) 17-Oct-2005 $7.49M $7.49M Completed Startup
1. Grant 01-Jan-2003 $125K Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Vascular Therapies Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series E2 0,000,000 00.000000 00 00 00 00 00 0.000
Series E1 0,000,000 00.000000 00 00 00 00 00 00.000
Series D 0,000,000 00.000000 00 00 00 00 00 00.000
Series C2 0,000,000 00.000000 00 00 00 00 00 00.000
Series C1 0,000,000 00.000000 00 00.00 00.00 00 00 0.000
Series B4 00,000 00.000000 00 00 00 00 00 0.000
Series B3 000,000 00.000000 00 00 00 00 00 0.000
Series B2 0,000,000 00.000000 00 00.00 00.00 00 00.00 0.00
Series B1 169,000 $0.001000 8% $0.01 $0.01 1x $0.01 0.05%
Series A4 316,667 $0.001000 8% $3 $3 1x $3 0.99%
To view this company’s complete Cap Table, request access »

Vascular Therapies Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
CNF Investments PE/Buyout Minority 000 0000 000000 0
Qualifying Therapeutic Discovery Project Government 000 0000 000000 0
The Gerrald Dorros and Myra S. Dorros Recovable Trust Other Minority 000 0000 000000 0
U.S. Department of Health and Human Services Government 000 0000 000000 0

Vascular Therapies Executive Team (6)

Name Title Board
Seat
Contact
Info
Sriram Iyer MD Founder, Chief Executive Officer, President and Board Member
Paul Barkofsky Ph.D Vice President, New Product Development
David Kornhauser Vice President of Regulatory Affairs
Rosanne Terraciano Vice President, Operations
Maureen Harrison Vice President, Quality Assurance

1 Former Executive

You’re viewing 5 of 6 executives. Get the full list »

Vascular Therapies Board Members (9)

Name Representing Role Since Contact
Info
Allan Tessler Self Board Member 000 0000
Andrew Midler Savitr Capital Board Member 000 0000
Dan Ryan Self Board Member 000 0000
Gerald Dorros MD The Gerrald Dorros and Myra S. Dorros Recovable Trust Board Member 000 0000
Kiyoshi Takesue Self Board Member 000 0000
You’re viewing 5 of 9 board members. Get the full list »